Loading provider…
Loading provider…
Urology Physician in San Francisco, CA
NPI: 1366461667Primary Practice Location
UCSF MEDICAL CENTER
1975 4th St, San Francisco, CA
Primary Employer
UCSF Medical Group Business Services
ucsfhealth.org
HQ Phone
Get M.D. Peter's Phone Numberphone_androidMobile
Get M.D. Peter's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
NY State Medical License
1984
CA State Medical License
1980 - 2025

American Board of Urology
Urology
Georgetown University School Of Medicine
som.georgetown.edu
Medical School
Until 1979
New York Presbyterian Hospital (Cornell Campus)
Residency • Urology
1984 - 1986
UCSF School of Medicine
medschool.ucsf.edu
Residency • Urology
1981 - 1984
Residency • Surgery
1979 - 1981
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 218 | 288 |
| 2 | 99203New patient outpatient visit, total time 30-44 minutes | 142 | 142 |
| 3 | 55866Surgical removal of prostate and surrounding lymph nodes using an endoscope | 69 | 69 |
| 4 | 52000Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | 64 | 85 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 53 | 55 |
Treatment Trends for Prostate Cancer—Reply
Authors: Matthew Cooperberg
Publication Date: 2015-11
Prostate cancer mortality following active surveillance versus immediate radical prostatectomy
Authors: Grossfeld, Gary D, Li, Yu-Ping, Lubeck, Deborah P, Broering, Jeanette M, Mehta, Shilpa S, Carroll, Peter R
Journal: J Urol
Lead Sponsor: Progenics Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: 18F-DCFPyL Injection, DIAGNOSTIC_TEST: PET/CT imaging
Lead Sponsor: University of California, San Francisco
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: BEHAVIORAL: Experimental: Arm 2 (Resist. Exercise), BEHAVIORAL: Experimental: Arm 1 (Aerobic Exercise)
Lead Sponsor: Stanford University
Collaborators: University of Mississippi Medical Center
Intervention / Treatment: DRUG: [18F]-FTC-146